Landmark moment in skin cancer vaccine trial
CBS News medical correspondent Dr. Céline Gounder joins "The Daily Report" to discuss what Moderna's melanoma vaccine breakthrough could mean as clinical trials continue.
Watch CBS News
CBS News medical correspondent Dr. Céline Gounder joins "The Daily Report" to discuss what Moderna's melanoma vaccine breakthrough could mean as clinical trials continue.
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Pharmaceutical company Moderna says it is scaling down its investments in late-stage vaccine trials amid growing opposition to immunizations from U.S. officials. CBS News medical contributor Dr. Céline Gounder breaks it down.
The new COVID-19 vaccine from Moderna, mNexspike, is made in a way that allows for a lower dose.
The Health and Human Services Department has canceled millions of dollars in funding for the drugmaker Moderna to develop a bird flu vaccine. CBS News health reporter Alex Tin has the details.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
COVID cases are growing or likely growing in 27 states, according to the CDC. This week, newly approved boosters from Moderna and Pfizer will be made available. Jeff Nguyen reports.
A vaccine and cancer drug dramatically improved survival rates for those with severe melanomas, results after three years showed.
Moderna plans to begin a late-stage trial later this year of its combination vaccines that offer protection against both COVID-19 and the flu. Dr. Stephanie Navarro Silvera, a professor in the Department of Public Health at Montclair State University, explains why a dual shot would be considered "a win in terms of public health."
The CDC has recommended updated COVID-19 vaccines that will be available for all people older than 6 months old. CBS News correspondent Elaine Quijano spoke with CDC director Dr. Mandy Cohen about the decision to include children in the recommendation.
Moderna asks FDA to authorize vaccine for young kids; Southen California water restrictions imposed.
"Truth is, [the] pharmaceutical industry is enormously greedy, charging us outrageously, uncontrollably high prices," the senator told "Face the Nation."
The company announced a patient assistance program as it prepares for government-bought supplies to run out.
Drug manufacturer Moderna says its COVID-19 vaccine could cost as much as $130 per dose once it switches to commercial distribution. The Biden administration announced last year that the federal government would no longer be paying for the vaccines. Kaiser Family Foundation senior vice president Dr. Jen Kates joins CBS News to discuss the potential new costs for the vaccine.
Moderna's stock soared after the COVID-19 vaccine maker detailed progress in developing a potential preventive shot for melanoma, a deadly form of skin cancer.
Recent small studies, not yet peer-reviewed, suggested the new boosters may not be significantly better than the original vaccine formula.
FDA recommends Moderna's booster shot for some adults; Several people killed in Afghanistan mosque explosion
Children ages 5 and up are now eligible to get the new COVID-19 booster shots, which target both the original coronavirus and its Omicron variants. CBS News medical contributor Dr. David Agus joins us to discuss the vaccine, and he also answers questions about a new study on colonoscopies.
The FDA has authorized an updated COVID-19 booster shot for children ages 5 years old and above. Dr. Dyan Hess, medical director for Gramercy Pediatrics, joins CBS News' Lana Zak and Errol Barnett to talk about the updated shot and what parents should know.
This week on "Face the Nation with Margaret Brennan," we'll have the latest on Ukraine with Samantha Power, the head of the U.S. Agency for International Development, and Virginia Democratic Sen. Tim Kaine. Then we'll hear from Illinois Rep. Adam Kinzinger; Dr. Paul Burton, the chief medical officer at Moderna; and Dr. Deborah Birx, the COVID-19 response coordinator during the Trump administration.
Providers have reported delays in shipments of Moderna's new shots, which make up some 20% of doses around the country.
President Biden said on CBS' "60 Minutes" the COVID-19 pandemic is over in the U.S. His comment came as updated booster shots are being rolled out across the country. Dr. Dyan Hes of Gramercy Pediatrics joined CBS News to discuss the latest.